UBS Group’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-46,300
Closed -$833K 8201
2018
Q2
$833K Sell
46,300
-147,100
-76% -$2.95M ﹤0.01% 3934
2018
Q1
$3.39M Buy
193,400
+155,000
+404% +$3.24M ﹤0.01% 2672
2017
Q4
$884K Buy
+38,400
New +$796K ﹤0.01% 3882
2017
Q1
Sell
-57,500
Closed -$1.55M 7897
2016
Q4
$1.55M Buy
+57,500
New +$1.42M ﹤0.01% 3143
2016
Q1
Sell
-145,000
Closed -$2.19M 8050
2015
Q4
$2.19M Buy
145,000
+50,000
+53% +$769K ﹤0.01% 2709
2015
Q3
$1.25M Buy
95,000
+65,000
+217% +$1.03M ﹤0.01% 3152
2015
Q2
$564K Buy
+30,000
New +$622K ﹤0.01% 4007
2015
Q1
Sell
-500
Closed -$8K 9244
2014
Q4
$8K Buy
+500
New +$10.5K ﹤0.01% 8596

Other funds holding PTEN

UBS Group's PTEN Position: Q1 2026 in Review

UBS Group reduced its Patterson-UTI (PTEN) stake by 65% in Q1 2026, selling an estimated $46.2M and leaving 2,919,491 shares worth $31.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

UBS Group first reported a position in PTEN in Q4 2014 and has held it in 46 quarters since. The position peaked at $50.8M in Q4 2025. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • UBS Group held 2,919,491 shares of Patterson-UTI worth $31.6M as of Q1 2026.
  • UBS Group sold 5,401,053 Patterson-UTI shares in Q1 2026, an estimated $46.2M.
  • Patterson-UTI made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2112 holding.
  • UBS Group first reported a position in Patterson-UTI in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Patterson-UTI position peaked at $50.8M in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.